EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia

Aran Koye iD, Simon Erridge iD, Evonne Clarke, Katy McLachlan, Ross Coomber, James J Rucker iD, Mark W Weatherall, Mikael H Sodergren iD

Neuropsychopharmacology Reports · 2026

DOI: 10.1002/npr2.70180 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neuropsychopharmacology Reports, 2026. Verfasst von Aran Koye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Cannabis Research Group, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Registries, Medical Marijuana. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insomnia disorder affects approximately 10% of people. The persistence of insomnia, despite treatment, remains high. Cannabis‐based medicinal products (CBMPs) have been proposed as a potential treatment for insomnia. This study aims to use data from the UK Medical Cannabis Registry to analyze changes in self‐reported sleep quality in patients prescribed CBMPs for insomnia.

Methods

A prospective cohort study of patients treated with CBMPs for insomnia was completed. The primary outcome was the Single‐Item Sleep Quality Scale (SQS). This was assessed at baseline and at 1, 3, 6, 12, 18, and 24 months from baseline. Secondary outcomes included change in anxiety and general health‐related quality of life. p ‐values < 0.050 were considered statistically significant.

Results

Two hundred and eleven participants met the inclusion criteria. Over half ( n = 126; 59.72%) were users of cannabis at baseline. At the primary endpoint of 24 months, mean SQS improved from 2.46 ± 2.10 (mean ± standard deviation (SD)) at baseline to 5.14 ± 2.75 (mean difference +2.68; 95% confidence interval (CI) 2.23–3.14; p < 0.001), with improvements observed at all timepoints. SQS values of 0 (odds ratio (OR) 15.49; 95% CI 3.87–65.19; p < 0.001) and 1–3 (OR 4.90; 95% CI 1.87–13.80; p = 0.002) at baseline and prescription of dried flower CBMPs (OR 4.99; 95% CI 1.27–21.39; p = 0.025) were associated with clinically significant improvements in sleep quality at 24 months. Seventeen participants (8.06%) reported adverse events. Participants aged over 60 were more likely to report an adverse event (OR 19.08; 95% CI 1.52–535.75; p = 0.036).

Conclusion

Initiation of CBMPs was associated with improvements in self‐reported sleep quality across 2 years, with the largest associations observed in those with the most severe impairment. As an uncontrolled, observational study of a self‐selected and predominantly cannabis‐experienced cohort, placebo effects, regression to the mean, and selection bias cannot be excluded.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersRegistriesMedical MarijuanaHumansFemaleMaleProspective StudiesMiddle AgedUnited KingdomAdultSleep QualityTreatment OutcomeCohort StudiesQuality of LifeAged

Stichwörter der Autor:innen

cannabidiolcannabisinsomniasleeptetrahydrocannabinol

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Medical Cannabis Research Group, Imperial College London, London, UK.
  • Curaleaf Clinic, London, UK.
  • St. George's University Hospitals NHS Trust, London, UK.
  • Department of Psychological Medicine, King's College London, London, UK.
  • South London & Maudsley NHS Foundation Trust, London, UK.

ORCID-Profile: Aran Koye, Simon Erridge, James J Rucker, Mikael H Sodergren

Zitieren

APA

Koye, A., Erridge, S., Clarke, E., McLachlan, K., Coomber, R., Rucker, J. J., Weatherall, M. W., & Sodergren, M. H. (2026). UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70180

Vancouver

Koye A, Erridge S, Clarke E, McLachlan K, Coomber R, Rucker JJ, et al. UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia. Neuropsychopharmacology Reports. 2026. doi:10.1002/npr2.70180

BibTeX
@article{Koye2026,
  author = {Koye, Aran and Erridge, Simon and Clarke, Evonne and McLachlan, Katy and Coomber, Ross and Rucker, James J and Weatherall, Mark W and Sodergren, Mikael H},
  title = {UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  doi = {10.1002/npr2.70180}
}
Kostenlos starten →